Stay updated on KN046 and Ningatinib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the KN046 and Ningatinib in Advanced HCC Clinical Trial page.

Latest updates to the KN046 and Ningatinib in Advanced HCC Clinical Trial page
- Check4 days agoChange DetectedA new revision label 'Revision: v3.3.3' was added, and the HHS Vulnerability Disclosure footer link along with 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry (v3.3.2) was added to the Study Record Versions, and the previous revision (v3.2.0) was removed.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the lapse-in-government-funding notice from the page; the standard government disclaimer remains visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check54 days agoChange DetectedVersion 3 (2022-10-26) updates the record with changes to recruitment status and study status. It also adds a Compare option to review differences between versions.SummaryDifference0.1%

- Check83 days agoChange Detected- Updated version from v3.1.0 to v3.2.0 and added a government-operational status notice. - Removed explicit reference to v3.1.0.SummaryDifference13%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.3%

Stay in the know with updates to KN046 and Ningatinib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN046 and Ningatinib in Advanced HCC Clinical Trial page.